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Abstract 14 
Objectives To review the literature concerning mortality associated with general anaesthesia 15 
in horses and to assess whether there is evidence for a reduction in mortality over the 16 
20 years since the Confidential Enquiry into Perioperative Equine Fatalities (CEPEF). 17 
Databases used PubMed, Scopus, Google Scholar. Search terms used: horse; pony; equine; 18 
anaesthesia; anesthesia; recovery; morbidity, and mortality. 19 
Conclusions The most recent studies, in which isoflurane and sevoflurane have been more 20 
commonly used for anaesthesia maintenance, report fewer intraoperative cardiac arrests than 21 
older studies in which halothane was favoured. Catastrophic fractures, however, have become 22 
the greatest cause of recovery-associated mortality. 23 
Keywords anaesthesia, anesthesia, equine, mortality, recovery. 24 
 25 
 Introduction 26 
Acknowledgement of changes in anaesthesia practice since the conclusion of the original 27 
Confidential Enquiry into Perioperative Equine Fatalities [CEPEF 1-3 (Johnston et al. 1995, 28 
2002, 2004)] led to plans for a further study [(CEPEF 4 (Bettschart & Johnson 2011; Gent & 29 
Bettschart-Wolfensberger 2013; Wohlfender et al. 2015)], the final results of which are 30 
eagerly awaited. Until those results become available, however, it is appropriate to review the 31 
mortality associated with equine anaesthesia and to investigate the developments that have 32 
occurred over the two decades since the publication of the first reports. 33 
 34 
Comparative mortality 35 
Mortality associated with equine anaesthesia has been reported to be approximately 1% in 36 
healthy elective cases, but figures have ranged from 0.08% to 1.8%, depending upon study 37 
design (Mitchell 1969; Tevik 1983; Young & Taylor 1990, 1993; Johnston et al. 1995, 2002, 38 
2004; Mee et al. 1998a, b; Bidwell et al. 2007) (Table 1). The number of postoperative days 39 
included, and whether or not anaesthesia was considered to be directly related to the outcome, 40 
affect the definition of ‘mortality’ [see below and Bidwell et al. (2007)]. Much higher 41 
mortality rates have been reported in emergency cases, particularly those requiring abdominal 42 
surgery for ‘colic’ (intra-abdominal conditions requiring surgical exploration) or Caesarean 43 
section, and range from 7.8% (Johnston et al. 2002) to 19.5%, even when animals with 44 
inoperable lesions are excluded (Mee et al. 1998b). The true contribution of anaesthesia to 45 
mortality in such cases is difficult to evaluate. Horses may survive emergency anaesthesia 46 
and colic surgery only to succumb to the complications of endotoxaemia and/or intractable 47 
postoperative ileus, or financial constraints may limit continued treatment in the early 48 
postoperative phase (Ducharme et al. 1983; Hunt et al. 1986). 49 
 The rate of ~ 1% that is considered to reflect the incidence of anaesthesia-associated 50 
mortality in healthy horses is between a hundred- and a thousand-fold greater than the 51 
incidences of mortality associated with anaesthesia in humans (0.01–0.001%) (Lunn & 52 
Mushin 1982; Jones 2001; Irwin & Kong 2014), 20-fold greater than that in dogs (0.05%), 53 
10-fold greater than that in cats (0.11%), and not dissimilar from that reported for rabbits 54 
(0.73%) (Brodbelt et al. 2008). There is, therefore, much room for improvement. 55 
Jones (2001) suggested that reductions in anaesthesia-related mortality, particularly for 56 
humans, had occurred over time as a result of the introduction of ‘safer anaesthetic 57 
techniques’ and attempts to reduce human error (through training and the use of existing and 58 
new monitoring devices). However, he also cautioned that the increasing complexity of 59 
surgery might offset some past and future improvements. In addition, Keats (1990) cautioned 60 
against the comparison of studies over time during which many factors were likely to change; 61 
he also suggested that anaesthetic mortality had not decreased ‘because we create new 62 
mechanisms of mortality at the same rate we solve them’. Irwin and Kong (2014) reminded 63 
us that although human anaesthesia itself may now be relatively safe, surgery is not! 64 
 65 
Equine mortality 66 
Several studies evaluating mortality associated with general anaesthesia and surgery in horses 67 
have identified various risk factors which may help to inform case management and/or 68 
highlight increased risk (Table 1). The largest study to date has been the CEPEF [n = 41,824, 69 
CEPEF 1 and 2 (Johnston et al. 1995, 2002); n = 11,336, CEPEF-3 (Johnston et al. 2004)]. 70 
This series of multicentre studies spanned over 8 years (February 1991 to September 1999) of 71 
data collection and identified the most common causes of death, as well as several risk factors 72 
(Table 1). 73 
 The CEPEF studies reported mortality rates of 0.9% in healthy horses within 7 days of 74 
anaesthesia and surgery, and 1.9% in all cases (including horses with colic or dystocia, foals, 75 
and horses undergoing fracture repair) (Johnston et al. 2002). A third of the deaths were 76 
attributed to intraoperative cardiac arrest or postoperative cardiovascular collapse, and around 77 
another third to fractures (limb or neck) and post-anaesthesia myopathy (PAM). 78 
Postoperative myopathy is associated with poor intraoperative muscle perfusion and oxygen 79 
delivery (Grandy et al. 1987) and it is likely that at least some of the fractures occurred as a 80 
consequence of myopathy-induced pain or weakness. 81 
In addition to CEPEF, several smaller-scale, single-centre studies have reported mortality 82 
rates between 0.08% and 1.5% in horses undergoing elective procedures (Mitchell 1969; Mee 83 
et al. 1998a; Senior et al. 2007; Bidwell et al. 2007; Dugdale et al. 2015). These values 84 
should be interpreted in the light of smaller sample sizes and differences in the horse 85 
populations served by each centre, and with consideration of the inconsistencies in definitions 86 
of ‘mortality’ between studies [see Senior (2013) for a recent review]. Furthermore, 87 
comparison between studies is also hindered by variations in anaesthetist experience. 88 
The largest single-centre study (n = 17,961) included almost half the number of horses in 89 
CEPEF-1 and 2, but reported mortality of only 0.12% in a sample that included horses 90 
undergoing emergency abdominal surgery (Bidwell et al. 2007). Half of these deaths were 91 
caused by intraoperative cardiac arrest and the remainder by PAM, neuropathy or fracture 92 
(Table 1). When all deaths occurring within the first 7 days post-surgery were included, the 93 
mortality rate doubled to 0.24%, which is still comparatively low (Bidwell et al. 2007). The 94 
majority of procedures, however, were of less than 1 hour in duration, which may have had a 95 
major influence on the results. 96 
The discrepancy between the mortality rates observed in the CEPEF study and those in the 97 
single-centre study reported by Bidwell et al. (2007) probably reflects the differences 98 
 between the very wide range of different practices, clinics and hospitals included in the 99 
CEPEF study, with their differences in caseloads, anaesthesia protocols and both anaesthetic 100 
and surgical experience, and a study conducted in a highly efficient single centre performing 101 
primarily short routine procedures in a relatively homogeneous group of patients with a 102 
uniformly high standard of anaesthetic care, respectively. Furthermore, even within equine 103 
hospitals, there is likely to be variation in experience and training amongst clinicians. To 104 
date, there is no evidence that lack of experience adversely influences equine anaesthesia-105 
associated mortality (Johnston et al. 2002). However, there is anecdotal evidence for the 106 
opposite, probably because the most experienced anaesthetists tend to be responsible for 107 
cases with the highest risk. Clearly, this requires further research. 108 
 109 
Causes of death 110 
Intraoperative cardiac arrest 111 
The CEPEF studies, in agreement with others, reported that intraoperative cardiac arrest 112 
tended to occur early in the anaesthetic period, usually within the first 30 minutes. This was 113 
considered to possibly result from halothane-induced myocardial sensitization to 114 
catecholamines, which may increase the risk for arrhythmias, especially in the absence of 115 
premedication, and it was suggested that acepromazine may be protective against such 116 
arrhythmias (Johnston et al. 1995, 2002; Mee et al. 1998a; Gent & Bettschart-Wolfensberger 117 
2013). Halothane was the most commonly used anaesthetic maintenance agent in several 118 
studies, including CEPEF-1 and 2 (Johnston et al. 1995, 2002; Mee et al. 1998a, b; Bidwell 119 
et al. 2007), which may have influenced the occurrence of adverse intraoperative cardiac 120 
events. In CEPEF-3, although overall mortality did not differ between isoflurane and 121 
halothane, fewer cardiac arrests occurred, especially in high-risk cases, when anaesthesia was 122 
maintained with isoflurane (Johnston et al. 2004). 123 
 In the most recent study, halothane was used only in occasional elective, healthy cases 124 
(Dugdale et al. 2015). Although no deaths attributable to cardiac arrest were reported, the 125 
study size was smaller (n = 1416) and contained few ‘athletic’ (racing or event-fit) horses, by 126 
contrast with that conducted by Bidwell et al. (2007), which reported four intraoperative 127 
cardiac arrests in mature ‘athletic’ horses originally deemed healthy. 128 
 129 
Axial and appendicular skeletal fractures 130 
Long bone, cervical or basal skull fractures during recovery have contributed to anaesthesia-131 
related mortality through immediate euthanasia or instantaneous death (Young & Taylor 132 
1993; Johnston et al. 2002, 2004; Bidwell et al. 2007; Dugdale et al. 2015). Fractures have 133 
been described as responsible for 26–64% of all anaesthesia-related fatalities, although in a 134 
study in which dislocations were included, this figure rose to 71% (Young & Taylor 1993; 135 
Johnston et al. 2002; Bidwell et al. 2007; Dugdale et al. 2015). 136 
Horses undergoing internal fracture fixation are considered at greater risk for the sustaining 137 
of further fractures in recovery, but such patients constituted only a small proportion (2.3–138 
5.0%) of the caseload in all the reports (Johnston et al. 1995, 2002; Bidwell et al. 2007; 139 
Dugdale et al. 2015). The reason for the differences in the incidence of fatal fractures among 140 
studies is unknown, and the sporadic nature of such occurrences may bias the data, especially 141 
in shorter-term studies which may simply be ‘lucky’ or ‘unlucky’. 142 
One potential explanation refers to whether or not assistance was provided during recovery. 143 
Bidwell et al. (2007), who reported the lowest incidence of mortality (eight of 17,961 cases, 144 
0.04%), assisted the majority of their cases with head and tail ropes, whereas Dugdale and 145 
colleagues (2015) rope-assisted only two of their cases (both fracture fixations). In one of 146 
these, the technique was deemed dangerous for both horse and assistants during recovery. 147 
The provision of rope-assisted recoveries was not reported in CEPEF. A more recent abstract 148 
 describing a study in which a rope recovery system was used for all horses reported that of 149 
5854 horses anaesthetized, 30 (0.51%) suffered major complications resulting in mortality, 150 
only two (0.03%) suffered fractures, and a single horse (0.02%) suffered a hock dislocation 151 
(Chie Niimura et al. 2015). 152 
Bidwell et al. (2007) emphasized that rope assistance cannot guarantee successful recovery, 153 
but others have been more convinced about its benefits. For example, Wilderjans (2005) 154 
reported no fractures, luxations or serious wounds in over 7000 non-fracture repair surgeries, 155 
whereas Auer & Huber (2013) reported no significant difference in recovery quality when 156 
horses were recovered with or without rope assistance following anaesthesia which 157 
incorporated a partial intravenous (IV) anaesthetic technique. Whether rope assistance or 158 
other forms of assistance can reduce the incidence of fracture remains to be unequivocally 159 
proven (Kaestner 2010), but rope-assisted recovery techniques appear to be gaining 160 
popularity. 161 
 162 
Post-anaesthesia myopathy 163 
Post-anaesthesia myopathy has been suggested to be a risk factor for the occurrence of 164 
fractures during recovery by causing pain, muscular weakness and incoordination. The 165 
importance of intraoperative cardiovascular monitoring and support, particularly the use of 166 
dobutamine to maintain mean arterial blood pressure (MAP) above values likely to risk PAM, 167 
has been highlighted by previous authors (Grandy et al. 1987; Richey et al. 1990; Young & 168 
Taylor 1993; Johnston et al. 2004). The provision of such support has been accepted practice 169 
in most equine hospitals since the early 1990s (Young & Taylor 1993). Indeed, partway 170 
through this study, increased intervention to support arterial blood pressure (MAP 171 
> 70 mmHg) resulted in fewer deaths and a reduction in the severity of PAM. This concurs 172 
with the more recent studies and supports the conclusion of Duke et al. (2006) that 173 
 intraoperative treatment of hypotension may not always prevent PAM, but it can reduce its 174 
severity. 175 
The occurrence of PAM, a form of compartment syndrome (with elements of ischaemia and 176 
later reperfusion injury), is associated with poor padding and positioning of the anaesthetized 177 
patient, a prolonged duration of anaesthesia, and hypotension, and has been extensively 178 
reviewed elsewhere (White & Suarez 1986; Grandy et al. 1987; Heppenstall et al. 1988; 179 
Lindsay et al. 1980, 1985, 1989; Richey et al. 1990; Taylor & Young 1990; Johnson 1993; 180 
Raisis 2005a, b). Although hypoxaemia would worsen tissue oxygen delivery already 181 
reduced by hypoperfusion/ischaemia, hypoxaemia itself has not yet been shown to be an 182 
independent risk factor for PAM (Trim & Wan 1990; Steffey et al. 1992; Whitehair et al. 183 
1996). In recent years, muscular disorders, which often present with prolonged recumbency 184 
during recovery and should be differentiated from true ischaemic PAM, have been 185 
characterized. The reader is referred elsewhere for details of equine polysaccharide storage 186 
myopathy, hyperkalaemic periodic paralysis and malignant hyperthermia or hyperpyrexia 187 
(Valentine 2005; Spier 2006; Aleman 2008; Finno et al. 2009; Naylor 2015). 188 
 189 
Spinal cord malacia/post-anaesthesia neuropathies 190 
Post-anaesthesia spinal cord malacia (pseudonyms include spinal cord myelopathy, 191 
myelomalacia, haematomyelia and poliomyelomalacia) can be considered a form of central 192 
neuropathy. It is recognized as a non-painful ascending neurological dysfunction which 193 
initially affects the tail and pelvic limbs (so that paraplegic horses may appear to ‘dog-sit’), 194 
and progresses cranially. It is effectively an ischaemic necrosis of the spinal cord, most 195 
commonly starting in the thoracolumbar area, and is invariably fatal. Its occurrence is 196 
sporadic and although young male horses of larger breeds undergoing relatively short 197 
procedures in dorsal recumbency appear to be at the greatest risk, cases have been reported in 198 
 mature horses (Ragle et al. 2011), fillies (Schatzmann et al. 1979; Blakemore et al. 1984; 199 
Brearley et al. 1986), a pony (Lam et al. 1995), and following lateral recumbency (Raidal 200 
et al. 1997). 201 
The aetiology of spinal cord ischaemia has not been elucidated and there are no 202 
recommended strategies for its prevention. Suggested initiating causes have included stretch 203 
ischaemia of the spinal cord during dorsal recumbency (possibly exacerbated by the 204 
haemodynamic consequences of dorsal recumbency and the associated increases in intra- and 205 
peri-spinal cord cerebrospinal fluid pressure), verminous arteritis, embolism (thrombo-, 206 
fibrocartilagenous or bone marrow), and vitamin E or selenium deficiency (Taylor et al. 207 
1977; Schatzmann et al. 1979; Blakemore et al. 1984; Zink 1985; Brearley et al. 1986; 208 
Fuentealba et al. 1991; Stolk et al. 1991; Lerche et al. 1993; Gruys et al. 1994; Jackson et al. 209 
1995; Lam et al. 1995; Raidal et al. 1997; Joubert et al. 2005; Brosnan et al. 2008; Ragle 210 
et al. 2011). It is difficult to explain why CEPEF-3 (Johnston et al. 2004) suggested that 211 
isoflurane was associated with more of these cases than halothane, although their dissimilar 212 
effects on systemic vascular resistance and myocardial contractility may be relevant 213 
(Grosenbaugh & Muir 1998; Durongphongtorn et al. 2006). 214 
Peripheral neuropathy affecting the limbs, such as femoral nerve injury, especially if 215 
bilateral, may prevent the animal from standing up. This may impact on postoperative 216 
management and ultimately result in euthanasia (Dyson et al. 1988). In addition, as the 217 
dysfunction associated with pure neuropathy is usually more of a problem than pain, it is 218 
tempting to speculate that predisposition to fractures may increase as proprioception is 219 
impaired alongside motor and other sensory dysfunction. Furthermore, neuropathy may 220 
accompany myopathy (e.g. triceps myopathy accompanied by radial neuropathy), in which 221 
case pain and lameness or weakness may influence the outcome, as well as potentially 222 
increase the likelihood of a long bone fracture. 223 
 Facial neuropathy is another form of peripheral neuropathy and is usually unilateral. It rarely 224 
results in mortality, but morbidities such as impairment of food prehension and/or ocular 225 
protection may warrant supportive treatment. 226 
Pure peripheral neuropathy usually results from neural trauma or ischaemia (caused by 227 
contusion, compression or stretch) and therefore careful patient positioning and padding, as 228 
well as good neural oxygen delivery (avoiding hypotension and hypoxaemia), should help to 229 
prevent it (Dyson et al. 1988; Johnson 1993). Over-extension of the head and neck during 230 
dorsal recumbency has been mooted as a cause of bilateral recurrent laryngeal nerve paresis 231 
or paralysis attributable to the stretching of these nerves, but the aetiology has not been fully 232 
determined (see below). 233 
 234 
Post-anaesthesia respiratory obstruction 235 
Post-anaesthesia respiratory obstruction (PARO) has been reported in several studies but at 236 
varying frequencies, including 3.7% in CEPEF (Johnston et al. 2002), 0.04–1.4% (Thomas 237 
et al. 1987), 0.3–1.5% (Senior et al. 2007), and 0.3% (Dugdale et al. 2015). This may reflect 238 
individual hospital-dependent factors, but may also refer to the inclusion of both non-fatal 239 
and fatal cases, which is not always clear in the published reports. 240 
Horses are obligate nose-breathers and hence nasal mucosal congestion and dorsal 241 
displacement of the soft palate after tracheal extubation are common causes of transient upper 242 
respiratory tract partial obstruction during recovery from anaesthesia. These are usually easily 243 
recognized soon after tracheal extubation (by stertor), and most cases can be quickly 244 
remedied (by placing a nasopharyngeal or nasotracheal tube, or replacing the orotracheal 245 
tube, until the congestion resolves), negating fatal consequences. Prophylactic topical nasal 246 
decongestants (e.g. phenylephrine) administered before the horse enters the recovery box are 247 
 effective, although the timing of application of the decongestant is important (Lukasik et al. 248 
1997). 249 
Lethal consequences of PARO may follow severe (complete or near-complete) respiratory 250 
obstruction caused by either physical hindrance (e.g. secondary to nasal mucosal congestion 251 
or nostril occlusion if a patient becomes awkwardly positioned during recovery), or 252 
laryngospasm or bilateral laryngeal paresis or paralysis (Dixon et al. 1993). Severe 253 
respiratory obstruction rapidly (within one or two attempted breaths) causes pulmonary 254 
oedema by two mechanisms: negative intrapulmonary pressure (generated during frantic, 255 
stridorous inspiratory efforts), and neurogenic influences (the hyperadrenergic state created 256 
by a massive sympathetic response to profound hypoxaemia, hypercapnia and distress results 257 
in increased pulmonary capillary pressure and permeability) (Lang et al. 1990; Tute et al. 258 
1996). Copious pink and frothy fluid emanates from the nostrils and mouth (during or shortly 259 
after relief of the obstruction) and the condition requires immediate treatment as soon as it is 260 
recognized to try to prevent fatality. 261 
Factors suggested to be linked to PARO include stretch or ischaemia of the recurrent 262 
laryngeal nerves (secondary to head and neck over-extension during dorsal recumbency, 263 
especially that which is prolonged), hypoxaemia and prolonged anaesthetic duration (Thomas 264 
et al. 1987; Abrahamsen et al. 1990; Ball & Trim 1996). Although intra-laryngeal nerve 265 
damage has been considered unlikely, the exact aetiology remains to be determined (Rooney 266 
& Delaney 1970; Goulden et al. 1975; Holland et al. 1986; Thomas et al. 1987; Heath et al. 267 
1989; Abrahamsen et al. 1990; Dixon et al. 1993; Ball & Trim 1996; Tute et al. 1996; 268 
Bradbury et al. 2008). 269 
Although any nostril occlusion-type obstruction is likely to be witnessed during recovery, 270 
safe intervention is not always possible. By contrast, respiratory obstruction associated with 271 
suspected bilateral recurrent laryngeal nerve paresis or paralysis tends to be delayed in onset 272 
 and may not be witnessed in time to instigate treatment. Obstruction has been reported to 273 
occur some time (minutes to hours) after the horse has stood up (without incident), and 274 
appears to coincide with the need for increased respiratory effort (Southwood et al. 2003; 275 
Southwood 2004; Dugdale et al. 2015). This increased respiratory effort may simply derive 276 
from attempts to whinny to horses walking past the recovery box, or, more alarmingly, from 277 
attempts to vocalize to neighbouring horses made while the patient is being led back to its 278 
stable. This latter situation on the yard often occurs a long way from help, equipment and 279 
drugs; hence, treatment may be delayed, with fatal consequences (Dugdale et al. 2015). 280 
 281 
Risk factors associated with mortality 282 
Several published studies of equine anaesthesia-associated mortality have reported a variety 283 
of risk factors which, if amenable to manipulation, may help to reduce mortality (Table 1). 284 
The most commonly reported risk factors have been American Society of Anesthesiologists 285 
(ASA) physical status, age, surgery type (especially emergency abdominal and internal 286 
fracture fixation), prolonged duration of anaesthesia and out-of-hours surgery (Tevik 1983; 287 
Young & Taylor 1990, 1993; Johnston et al. 1995, 2002, 2004; Mee et al. 1998a, b; Chie 288 
Niimura et al. 2015; Dugdale et al. 2015). 289 
 290 
ASA physical status 291 
Worsening physical status (ASA grade) has long been associated with an increased risk for 292 
mortality (Tevik 1983; Mee et al. 1998a, b; Johnston et al. 2004; Dugdale et al. 2015). 293 
Although horses suffering from colic with attendant hypovolaemia and endotoxaemia are 294 
readily assigned the higher ASA grades, Bidwell and colleagues (2007) reported increased 295 
mortality in horses presenting with pyrexia and/or increased white blood cell counts. These 296 
latter indicators of ill health may be either misinterpreted (e.g. pyrexia may be attributed to 297 
 stress or anxiety), or undiscovered (e.g. if full haematology does not form part of the pre-298 
anaesthetic assessment in animals otherwise perceived as healthy), resulting in the assigning 299 
of falsely low ASA grades. Mares in the last trimester of pregnancy are also at increased risk 300 
for mortality and are often assigned higher ASA grades in view of their reduced physiological 301 
reserves during late gestation (Johnston et al. 1995). Brood mares, especially older and 302 
multigravida mares, appear to be particularly prone to long bone fractures, probably because 303 
of osteopaenia (Glade 1993; Johnston et al. 1995). In addition, heavily pregnant mares may 304 
present with signs of colic and/or exhaustion as a result of dystocia or other abdominal crises, 305 
which require emergency surgery, commonly outside of normal working hours. 306 
 307 
Age 308 
The association of older age with increasing risk for mortality has been reported in several 309 
studies (Johnston et al. 1995, 2002, 2004; Dugdale et al. 2015). However, CEPEF included 310 
sufficient younger animals to suggest that foals, particularly in the first month and if sick, 311 
were also at increased risk. This was especially clear if anaesthesia was induced with a 312 
volatile agent; halothane was the most commonly used agent at that time (Johnston et al. 313 
1995, 2002, 2004). 314 
Age may also influence fracture incidence during recovery because older animals are more 315 
likely to suffer comorbidities and to have osteoporosis, especially older brood mares (Jones 316 
1989; Glade 1993). Furthermore, age may compound the effects of fatigue in older animals 317 
presenting for colic surgery (Johnston et al. 2002; Bidwell et al. 2007). Indeed, horses which 318 
suffer fractures in recovery do not all appear to have violent recoveries (Young & Taylor 319 
1993). Hence, underlying muscle weakness or ataxia, of whatever cause, is thought to 320 
increase the torque experienced by the long bones which, in turn, may result in their 321 
structural failure. 322 
 Surgery type and recumbent position 323 
Emergency abdominal surgeries and internal fracture fixation have been associated with 324 
greater mortality across a number of studies (Johnston et al. 1995, 2002, 2004; Dugdale et al. 325 
2015). Part of this association, however, may reflect the prolonged anaesthesia time required 326 
by these more invasive surgical procedures (see below). 327 
Mee et al. (1998a, b) reported mortality rates of 2.0% in non-colic emergencies and 4.3% in 328 
horses undergoing emergency exploratory coeliotomy. This greater mortality affecting horses 329 
with colic was considered a result of the probably pre-existing cardiovascular compromise 330 
and greater ASA grade. Although colic-related anaesthesia mortality seems to have improved 331 
more recently [1.6% (Dugdale et al. 2015)], this improvement may derive from the earlier 332 
referral of cases (fewer cases with high ASA grades), improved anaesthetic technique, and a 333 
greater incidence of intraoperative euthanasia based on increasing evidence regarding 334 
longterm prognosis (Proudman et al. 2002a, b, 2006). Colic cases with the poorest prognoses 335 
were more likely to be euthanized early in the course of anaesthesia; this would explain the 336 
association of non-resection colics and short periods of anaesthesia with increased mortality 337 
(Dugdale et al. 2015). 338 
Dorsal recumbency, maintenance of anaesthesia with isoflurane or sevoflurane [compared 339 
with halothane, desflurane or total IV anaesthesia (TIVA); see below], and increasing age 340 
were initially associated with increased mortality in the recent Liverpool study, but these 341 
factors were also covariates with colic surgery (Dugdale et al. 2015). Confounding of dorsal 342 
recumbency and exploratory coeliotomy as potential explanatory or predictor variables for a 343 
poorer outcome has already been demonstrated in previous studies, which highlights the 344 
importance of multivariable statistical modelling for the interpretation of data (Johnston et al. 345 
1995, 2002). 346 
 Recumbency has been variably linked with mortality and the dorsal position has usually been 347 
associated with the worst outcome (Johnston et al. 1995; Mee et al. 1998b; Dugdale et al. 348 
2015). Recumbency is, however, a strong covariate of surgery type. Lateral recumbency and 349 
prolonged duration of anaesthesia were associated with increased risk for PAM, but not for 350 
mortality, in CEPEF-3 (Johnston et al. 2004) and were considered in detail by Young (1993). 351 
 352 
Anaesthesia and surgery duration 353 
Longer duration of anaesthesia has been associated with higher mortality in several studies 354 
[> 2 hours (Tevik 1983); 163 minutes versus 74 minutes (Young & Taylor 1990); > 2 hours 355 
and especially > 4 hours (Johnston et al. 1995)], possibly because it is linked with more 356 
complex surgical interventions. Two studies reported an association between a short duration 357 
of anaesthesia and increasing mortality, but this simply reflected early euthanasia in cases 358 
with poor prognoses (Mee et al. 1998b; Dugdale et al. 2015). 359 
Longer anaesthesia leading to more time during which the concentration of anaesthetic in the 360 
brain is within a hypothetical ‘ataxic range’ would promote incoordination during recovery 361 
(Young & Taylor 1993). The generally shorter periods of anaesthesia (the majority were 362 
< 1 hour) reported by Bidwell et al. (2007) appear to have made a significant contribution to 363 
the relatively low immediate mortality (0.12%) identified by this group. By contrast with 364 
many other species, horses must stand up in the early postoperative period and there does not 365 
appear to be one fail-safe method to assist this process [for reviews, see Driessen (2005) and 366 
Clark-Price (2013)]. However, during the recent online survey conducted prior to CEPEF-4, a 367 
notable 40% of questionnaire respondents recorded the provision of some form of assistance 368 
during the recovery process (Wohlfender et al. 2015). 369 
 370 
 371 
 Out-of-hours procedures requiring general anaesthesia 372 
Even after adjusting for emergency abdominal procedures such as colic-related interventions 373 
and Caesarean sections (i.e. in patients with higher ASA scores), mortality remained higher in 374 
out-of-hours procedures (Johnston et al. 1995, 2002). The recent attention to developing a 375 
‘safety culture’ in the workplace has refocused attention on human factors. These include the 376 
reductions in vigilance, cognitive function and psychomotor skill performance (most notable 377 
at the time of a circadian nadir) associated with sleep deprivation, circadian rhythm 378 
disturbance and fatigue (Williamson & Feyer 2000; Ferguson et al. 2014). Around three-379 
quarters of all critical incidents in aviation and anaesthesia are caused by human error and 380 
fatigue appears to contribute to the majority of these (Howard et al. 2002; Rampersad & 381 
Rampersad 2012). Longer-term consequences of shift work and chronic sleep deprivation 382 
include both mental and physical illness. We have, however, also to determine the impacts of 383 
anaesthesia and surgery on the patient at its own circadian nadir. 384 
Although most of us have little control over our working days, recognition of one’s own 385 
chronotype (morning lark or night owl), and awareness of the onset of one’s own or others’ 386 
fatigue can at least warn of the increasing level of risk associated with continued working. 387 
Fatigue can be assessed using the Samn Perelli Fatigue Checklist or the Karolinska 388 
Sleepiness Scale (Richter et al. 2005), the use of which may also increase the chance that 389 
team members will look out for one another (Caldwell et al. 2008; Toff 2010). In addition, 390 
tactics to help maintain vigilance are worth investigating and include strategies such as 391 
regular intake of healthy meals or snacks, regular intake of water to maintain hydration, 392 
intake of caffeine (although this may have only short-term effects as tolerance can develop), 393 
exercise if possible, napping if possible, the use of bright lights in theatre, the use of 394 
checklists and the use of appropriately set, alarmed monitoring devices (Ferguson et al. 2014; 395 
Gregory & Edsell 2014). The importance of teamwork and good communication was 396 
 emphasized in a special issue of the British Journal of Anaesthesia (Hardman & Moppett 397 
2010) devoted to human factors. We should try to accept that we are all human, embrace 398 
modern, mindful views of ‘professionalism’ (Armitage-Chan 2014), and keep in mind this 399 
warning from Weinger & Ancoli-Israel (2002): ‘Physicians must recognize that it is neither 400 
unprofessional nor weak to admit sleepiness or fatigue when on the job and make efforts to 401 
mitigate the potential consequences to patient care.’ 402 
 403 
Anaesthetic agents, techniques and monitoring 404 
Although most of the patient- and surgery-related factors associated with mortality are not 405 
amenable to manipulation, anaesthetic-related factors may be. Mitchell (1969) suggested that 406 
premedication was beneficial and Johnston et al. (1995) reported that lack of premedication 407 
was associated with increased mortality. After cases of colic surgery and Caesarean section 408 
were excluded from analysis, Johnston et al. (2002) later reported that the inclusion of 409 
acepromazine reduced mortality. 410 
Mortality was also reduced when TIVA was employed (Johnston et al. 2002; Bidwell et al. 411 
2007; Dugdale et al. 2015). Although many instances of TIVA were likely to have been 412 
applied in less complicated procedures of relatively short duration, these are not universal 413 
features and may reflect a true benefit of injectable anaesthetic agents. In support of this, 414 
TIVA techniques have been associated with a reduced stress response (Taylor 1989, 1990; 415 
Taylor et al. 1995). 416 
The protective effects of acepromazine presumably include its anxiolytic actions, which 417 
reduce circulating catecholamines that might otherwise favour the development of cardiac 418 
dysrhythmias. In addition, its mild sedative effects may reduce anaesthetic induction and 419 
maintenance requirements and may contribute to calmer recoveries. Benefit from 420 
acepromazine is also apparent when it is included in protocols in which α2-agonists are used 421 
 (Marntell et al. 2005). In such circumstances, tissue perfusion is improved through enhanced 422 
cardiac output because of reduced systemic vascular resistance and increased heart rate. This 423 
potential increase in tissue oxygen delivery is probably somewhat offset by a reduction in 424 
haematocrit caused by the splenic sequestration of erythrocytes (Marntell et al. 2005), but this 425 
may improve blood flow as a result of the reduced viscosity (Stone et al. 1968; Spier & 426 
Meagher 1989). The reduction in haematocrit is probably attributable to both the 427 
acepromazine and the α2-agonist (Parry & Anderson 1983; Kullman 2011). The reduction in 428 
systemic vascular resistance, however, may make hypotension more likely during anaesthesia 429 
(Parry et al. 1982). 430 
Hypotension is a known causative factor for PAM and arterial blood pressure monitoring has 431 
been associated with a reduction in the severity of PAM; thus the importance of arterial blood 432 
pressure monitoring and support cannot be overemphasized (Young & Taylor 1993; Duke 433 
et al. 2006). Furthermore, arterial blood pressure monitoring appears to reduce mortality 434 
caused by intraoperative cardiac arrest (Johnston et al. 2004), possibly by increasing the 435 
vigilance of the haemodynamic status of the patient. 436 
Although isoflurane has been found to be associated with a lower incidence of cardiac arrest 437 
than halothane, an apparent increase in the number of spinal cord malacia cases with 438 
isoflurane (compared with halothane) implies the absence of any overall difference in 439 
mortality between these two agents [CEPEF-3 (Johnston et al. 2004)]. Dugdale and 440 
colleagues (2015) reported greater mortality with isoflurane and sevoflurane in comparison 441 
with all other maintenance agents. This is most probably attributable to their more frequent 442 
general usage and a preference for their use over other agents in sicker horses undergoing 443 
long procedures. 444 
Volatile anaesthetic agents are convenient for maintenance of prolonged anaesthesia, but the 445 
more fat-soluble compounds (halothane, sevoflurane) accumulate in adipose tissue and can 446 
 prolong recovery time (i.e. they have context-sensitive decrement times) in a manner 447 
somewhat reminiscent of the way in which injectable agents can accumulate (i.e. they have 448 
context-sensitive half times). Nevertheless, hepatic metabolism offers an alternative 449 
elimination strategy for halothane (of which ~ 20% is metabolized) and sevoflurane (of 450 
which ~ 2% is metabolized), which can, to some degree, offset the effect of their greater fat 451 
solubility on prolonging the recovery from anaesthesia. The hepatic metabolism of isoflurane 452 
(~ 0.2%) and desflurane (~ 0.02%) has a negligible effect on recovery. Volatile agents also 453 
produce marked dose-related cardiopulmonary depression and a related profound stress 454 
response. Despite the fact that the halo-ethers isoflurane and sevoflurane have replaced 455 
halothane (a halo-hydrocarbon) for anaesthetic maintenance, isoflurane in particular has been 456 
associated with poorer recovery quality compared with halothane (Grosenbaugh & Muir 457 
1998; Matthews et al. 1998; Donaldson et al. 2000), and the quality of recovery following 458 
sevoflurane may not always be superior to that following isoflurane (Leece et al. 2008). The 459 
influence of desflurane, another halo-ether but with very low blood and fat solubility, on 460 
recovery quality has also been equivocal (Jones et al. 1995; Clarke et al. 1996; Tendillo et al. 461 
1997; Valente et al. 2015). It seems that the replacement of halothane with halo-ethers, 462 
particularly isoflurane, has reduced the incidence of intraoperative cardiac arrest at the price 463 
of producing more complications during recovery, especially fractures, which currently 464 
appear to represent the leading cause of fatality. 465 
The current vogue for ‘partial/supplemental IV anaesthesia’, which is intended to provide 466 
balanced anaesthesia and analgesia with better preservation of cardiopulmonary function and 467 
a less marked stress response, by using injectable agents to reduce the required dose of 468 
inhalation agents, also reflects efforts to improve the quality of recovery (Auckburally & 469 
Flaherty 2011; Gozalo-Marcilla et al. 2014, 2015). It remains to be seen, however, whether 470 
 this approach will reduce the morbidity and mortality associated with equine anaesthesia and 471 
surgery. 472 
Larger volumes of intraoperative crystalloid fluid administration were associated with 473 
increased mortality in one study (Young & Taylor 1990), but prolonged duration of 474 
anaesthesia was also reported as a risk factor that would have influenced the total fluid 475 
volume administered. Nevertheless, excessive crystalloid fluid administration, resulting in 476 
widespread tissue congestion and oedema, is associated with increased human and feline 477 
morbidity (Holte et al. 2002; Grocott et al. 2005; Cotton et al. 2006; Brodbelt et al. 2007). 478 
Fluid therapy guidelines have been recently reviewed for small animals (Davis et al. 2013), 479 
and are currently under renewed scrutiny for people (National Institute for Health and Care 480 
Excellence 2013). Much of the debate regarding perioperative fluid therapy surrounds the 481 
interactions of different types of fluid with the endothelial glycocalyx and their 482 
immunomodulatory effects (Boldt 2000; Gosling 2003; Lang et al. 2003; Chappell et al. 483 
2008; Muir 2009; Boldt & Ince 2010). Colloids, such as hydroxyethyl starches, and 484 
hypertonic saline can have useful effects in the face of a systemic inflammatory response, 485 
although the timing of administration may be important (Gosling 2003; Strandvik 2009). 486 
However, colloids, especially the hydroxyethylated starches, have recently been blamed for 487 
causing nephrotoxicity when used for haemodynamic support in critically ill humans, 488 
although they were, in these instances, used in huge, and repeated, doses (Chan et al. 1983; 489 
Allen et al. 1986; Mythen 2005; Brandstrup 2006; Lobo et al. 2006; Santry & Alam 2010; 490 
Nolan & Mythen 2013). Although colloids remain indicated for the treatment of acute 491 
hypovolaemia or oncotic support, the Pharmacovigilance Risk Assessment Committee 492 
(PRAC) of the European Medicines Agency recommends monitoring renal function 493 
(Myburgh 2015). Nephrotoxicity may also result from the administration of crystalloid fluids 494 
containing high chloride concentrations, partly because the resultant 495 
 hyperchloraemia/hyperchloraemic acidosis causes renal vasoconstriction (Schneider & 496 
Bellomo 2013). For further information about current research and controversies in fluid 497 
therapy, the reader is referred to the various proceedings of the annual ‘Great World Fluid 498 
Debates’ held by the Congress in Evidence-Based Perioperative Medicine (EBPOM). 499 
 500 
Recovery quality 501 
Only one study has reported an association between recovery score and mortality (Young & 502 
Taylor 1990). This is probably because horses that die during anaesthesia or never stand up 503 
during recovery cannot be assigned a recovery quality score. Furthermore, although it is 504 
tempting to presume that the recovery of horses that suffer a catastrophic fracture must have 505 
been violent, this is clearly not always the case (Young & Taylor 1993). Only one other 506 
group has investigated recovery score as a potential factor influencing mortality, but found no 507 
association (Mee et al. 1998a, b), possibly because its analysis included intraoperative deaths. 508 
Recovery quality is influenced by the same factors that affect mortality [age, ASA physical 509 
status, surgery, body position, anaesthesia duration and out-of-hours surgery (Young & 510 
Taylor 1990; Taylor & Young 1993; Dugdale et al. 2015)]. Increasing body mass, which has 511 
been considered an important factor for some time (Johnston 1992), has recently been shown 512 
to be associated with recovery quality (Franci et al. 2006; Dugdale et al. 2015), as has horse 513 
temperament (Leece et al. 2008). 514 
The longer the period of anaesthesia maintenance with volatile agents, the less likely the 515 
anaesthetic induction agents are to affect the course of anaesthesia and recovery (Taylor & 516 
Yong 1993). A recent abstract reported poorer recoveries in six horses when midazolam was 517 
used in conjunction with ketamine for anaesthesia induction than when propofol was used in 518 
conjunction with ketamine, before 1 hour of isoflurane anaesthesia (Jarrett et al. 2015). 519 
Poorer recovery scores following midazolam–ketamine anaesthesia inductions were 520 
 associated with a higher residual percentage of midazolam in the plasma at the start of 521 
recovery compared with propofol, but the dose of midazolam used (0.1 mg kg−1) was also 522 
higher than is commonly described. The influence of sedative agents given at the time of 523 
premedication on recovery quality has yet to be fully determined, but TIVA techniques and 524 
sedation in early recovery may improve recovery quality (Santos et al. 2003; Ida et al. 2013; 525 
Woodhouse et al. 2013; Dugdale et al. 2015). 526 
 527 
Conclusions 528 
We are still a long way from greatly reducing the mortality associated with equine 529 
anaesthesia. Improvements have been made, such as in the monitoring and supporting of the 530 
cardiovascular system, so that anaesthesia itself is less likely to be fatal; however, we still 531 
lose horses after anaesthesia to a range of catastrophes that would not occur if the horse were 532 
not anaesthetized. Probably the most notable development is the increased emphasis on 533 
fractures that occur during the recovery period and necessitate euthanasia. 534 
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 Table 1  Mortality and reported risk factors associated with equine anaesthesia in studies published between 1969 and 2015, and morbidity 865 
prevalence and associated risk factors in a four-centre UK study published in 2007 866 
Study Mortality Causes of death Excluded risk factors Identified risk factors 
Mitchell (1969) 
Single centre, 
included emergency 
and elective cases 
Exact postoperative 
follow-up time not 
documented 
(Data collected Jan 
1962 to Dec 1969) 
7/473 (1.5%) 
Deaths thought 
solely due to 
anaesthetic 
problems: 4/473 
(0.85%) 
Two cardiac arrests (one 
followed acepromazine 
premedication and 
thiopental induction; one 
followed promazine 
premedication and 
thiopental/suxamethonium 
induction) 
One chloroform overdose 
One malposition and 
occlusion of head/neck 
blood flow 
No statistical evaluations 
performed; purely 
descriptive 
Note that most procedures were of 20–50 minutes 
in duration 
Pre-anaesthetic medication was suggested to be 
desirable to smooth the anaesthetic process 
 One paraplegic pony died 
under GA when 
manoeuvred, possibly as a 
result of disturbance of 
the fracture site 
One pathological femoral 
fracture and massive 
haematoma that 
developed during 
recovery following pelvic 
radiographs (horse 
severely lame beforehand) 
One pony with grass 
sickness had C-section for 
delivery of premature foal 
but died 24 hours later 
 Tevik (1983) 
Single centre, 
included emergency 
and elective cases 
Time frame of 
postoperative horse 
observation not 
specified, but 
> 24 hours 
(Data collected 1965 
to 1981) 
33/1216 (2.7%) 
Anaesthesia 
considered main 
cause of 10 deaths 
occurring within first 
24 hours of surgery 
10/1216 (0.8%) 
However, a further 
eight animals died 
from PAM within 
the following 36–
96 hours post-
surgery: 
18/1216 (1.5%) 
Deaths during 
anaesthesia and in the 
first 24 hours post-
surgery: 
CVR depression, n = 7 
Cardiac arrest after 
suxamethonium 
administration, n = 2 
Asphyxiation after ETT 
removed too early, n = 1 
Others, n = 13 
Deaths > 24 hours post-
surgery: 
PAM, n = 8 
Peritonitis, n = 1 
Ruptured ventricle, n = 1 
Age Poorer ASA physical status 
Surgery/anaesthesia of > 2 hours 
‘Good risk’ patients noted to be at particular risk 
for PAM 
 Young & Taylor 
(1990) 
(preliminary data) 
Single centre 
Time frame of 
postoperative horse 
observation not 
specified, but 
appeared to be up to 
3 days 
Overall mortality: 
9/498 (1.8%) 
PAM, n = 6 
Neuropathy, n = 1 
Fracture, n = 1 
Halothane overdose, n = 1 
 Prolonged anaesthesia time (163 minutes for 
‘disasters’ versus 74 minutes) 
Low pulse rate during maintenance 
(29 beats minute−1 versus 34 beats minute−1) 
Low diastolic pressure 
Low breathing rate 
Age (10.4 years versus 6.1 years) 
Volume of crystalloids administered (7.7 L versus 
1.4 L) 
Type of surgery 
Recovery quality 
Time to achieve sternal recumbency in recovery 
(43 minutes versus 28 minutes) 
Young & Taylor 
(1993) 
(definitive data) 
Overall mortality 
(colics excluded): 
9/1314 (0.68%) 
PAM, n = 6 (associated 
with re-fractures, n = 2) 
Cervical fracture*, n = 1 
Factors investigated for 
potential associations with 
recovery score as an 
Improved recoveries were noted to occur with: 
shorter GA duration; less invasive surgery (a 
covariate of the above); longer recovery time; 
 Single centre, 
excluded emergency 
colics 
Time frame of 
postoperative horse 
observation not 
specified, but 
appeared to be up to 
3 days 
(Data collected 1984 
to 1990) 
Total morbidity: 
19/1314 (1.4%) 
Patella luxation*, n = 1 
Femoral nerve 
neuropathy, n = 1 
Transient (~ 2 hours) 
blindness, n = 1 
Halothane overdose, n = 1 
(Further cases of PAM 
recovered, n = 8) 
*Not noted as a 
particularly violent 
recovery 
acknowledgement of the 
recovery phase as the 
period during which many 
problems arise or become 
apparent 
lower pulse rate at induction, and higher pulse rate 
and breathing rate during maintenance 
Although treatment of hypotension had no effect on 
recovery quality or PAM occurrence, it did 
decrease the severity of PAM 
Johnston et al. 
(1995) 
(preliminary 
CEPEF-1) 
Multicentre 
All perioperative 
until 7 days post-
surgery: 
102/6255 (1.6%) 
Not specified by cause Sex 
Many breeds: 
Thoroughbreds; 
Thoroughbred crosses; 
Age (foals aged < 3 months and horses aged 
> 12 years at increased risk compared with referent 
category of 2–4 year-olds) 
Last trimester of pregnancy associated with 
increased risk 
 Time frame of 
postoperative horse 
observation included 
the first 7 days post-
surgery 
(Data collected Feb 
1991 to Mar 1993) 
Perioperative deaths 
until 7 days post-
surgery, excluding 
emergency 
abdominal surgeries: 
46/5220 (0.9%) 
Warmbloods; Hunters; 
Arabs; ponies, and Shires 
‘Cob’ breed associated with increased risk 
Emergency abdominal surgery associated with 
increased risk 
Internal fracture fixation associated with increased 
risk 
Dorsal recumbency associated with greater risk 
than either lateral* 
Duration of surgery (> 120 minutes and especially 
> 240 minutes increase risk)*† 
Out-of-hours surgery increases risk, especially 
during 18.00–09.00 hours compared with referent 
category of 08.01–13.00 hours* 
Season (Oct–Dec decreased risk compared with 
referent category of Apr–Jun) 
No premedication increased risk* 
Xylazine premedication increased risk* 
 Acepromazine premedication appeared protective* 
Inhalation induction with halothane increased risk, 
especially in foals, compared with referent category 
of GG + thio 
Induction with GG + ketamine increased risk 
compared with referent category of GG + thio* 
*All potentially confounded by colics and 
emergency abdominal procedures 
†Fracture fixation surgeries are likely to confound 
anaesthetic duration 
Mee et al. (1998a) 
Single centre, 
elective cases 
Horses followed 
post-surgery until 
hospital discharge 
Elective cases 
(included some re-
laparotomies) 
8/1279 (0.63%) 
Cannon bone fracture, 
n = 1 
Postoperative 
haemorrhage at surgical 
site, n = 1 
Age 
Sex 
Breed 
Use of horse 
Body mass 
Duration of anaesthesia 
Physical status: increasing illness increased risk for 
mortality 
 (maximum of 
3 weeks) 
(Data collected Feb 
1991 to Dec 1995) 
Anaesthesia alone 
blamed for 1/1279 
(0.08%) 
Repeat laparotomies with 
shock-related deaths, 
n = 3 
Cardiac arrest possibly 
related to unforeseen 
hyperkalaemia, n = 1 
Respiratory arrest at 
8 hours after thoracotomy, 
n = 1 
Intraoperative respiratory 
then cardiac arrest 
unresponsive to 
resuscitation, n = 1 
Body position 
Recovery quality 
Mee et al. (1998b) 
Single centre, 
emergency cases 
4/203 operable non-
colic emergencies 
(2.0%) 
Emergency non-colic 
deaths: 
Between non-colics and 
colics: 
Age 
Between non-colics and colics:- 
Physical status – increasing ASA grade increased 
risk of mortality 
 Horses followed 
post-surgery until 
hospital discharge 
(maximum of 
3 weeks) 
(Data collected Feb 
1991 to Dec 1995) 
124/635 operable 
colics (19.5%) 
Intraoperative cardiac 
arrest (ruptured bladder 
foal), n = 1 
Postoperative 
haemorrhage (guttural 
pouch mycosis; pelvic 
abscess), n = 2 
Unknown, died 5 days 
post-surgery for over-
reach injury, n = 1 
Emergency colic 
intraoperative deaths: 
Cardiac arrests, n = 13 
Ventricular fibrillation, 
n = 2 
Haemorrhage, n = 2 
Sex 
Breed 
Use of horse 
Body mass 
Duration of anaesthesia 
Recovery quality 
Within ‘colics’: 
Age 
Sex 
Breed 
Use of horse 
Body mass 
Body position 
Recovery quality 
Body position (but probably confounded by ‘colic’) 
Within ‘colics’  
Physical status: increasing ASA grade increased 
risk for mortality. 
Duration of anaesthesia (short GA associated with 
higher mortality but confounded by early 
euthanasia of cases with poor prognoses) 
 Emergency colic 
postoperative deaths: 
Failed to stand, n = 1 
Shock, n = 12 
Postoperative ileus, n = 1 
Unknown, n = 3 
Emergency colic 
postoperative 
euthanasias: 
Fractures in recovery, 
n = 2 
PAM/N, n = 4 
Shock, postoperative 
ileus, laminitis, n = 52 
Peritonitis/rupture, n = 16 
Diarrhoea, n = 6 
 ‘Unusual’ causes, n = 10 
Johnston et al. 
(2002) 
(CEPEF-1 and 2) 
Multicentre 
Time frame of 
postoperative horse 
observation included 
the first 7 days post-
surgery 
(Data collected Feb 
1991 to Mar 1994 
for CEPEF-1, and 
Apr 1994 to Feb 
1997 for CEPEF-2) 
All perioperative 
deaths up to 7 days 
post-surgery: 
785/41,824 (1.9%) 
Perioperative deaths 
up to 7 days post-
surgery, excluding 
emergency 
abdominal surgeries: 
328/35,978 (0.9%) 
Perioperative deaths 
up to 7 days post-
surgery in 
colics/emergency 
abdominal surgeries: 
Deaths in non-emergency 
abdominal surgeries: 
Intraoperative cardiac 
arrest/postoperative CV 
collapse, n = 109 
Fractures, n = 84 
PAM, n = 23 
Abdominal, n = 43 
CNS/spinal cord malacia, 
n = 18 
Respiratory 
complications, n = 12 
Postoperative 
haemorrhage, n = 4 
Found dead, n = 15 
Sex 
Breed 
Body position (too many 
confounders) 
Season (too many 
confounders) 
Age (< 1 month suggested to be associated with 
increased risk in abstract but not supported by 
statistical model;  14 years showed some increase 
in risk but not quite statistically significant; 
> 12 months to 5 years associated with least risk; 
referent category 5 years to < 14 years) 
Fracture repair surgeries associated with greatest 
risk compared with referent ENT surgeries 
Out-of-hours surgery (any time outside the referent 
category of 06.00–13.00 hours increased risk; but 
worst was 00.00–06.00 hours 
Acepromazine premedication suggestive of 
reduced risk but did not reach statistical 
significance 
 457/5846 (7.8%) Other, n = 20 TIVA protective but total inhalational technique 
associated with increased risk, when compared 
with referent category of IV induction with IH 
maintenance (TIVA anaesthetics tended to be of 
< 90 minutes in duration) 
Duration of anaesthesia was not modelled because 
of early intraoperative deaths in which cardiac 
arrest occurred. However, the authors suggest that 
prolonged procedures were associated with greater 
risks and internal fracture fixation surgeries are 
amongst the longest 
Johnston et al. 
(2004) 
(CEPEF-3) 
Multicentre 
All perioperative 
deaths up to 7 days 
post-surgery: 
134/8242 (1.6%) 
Cardiac arrests, n = 43 
Fractures, n = 31 
PAM‡, n = 10 
Respiratory 
complications, n = 6 
 Physical status: worsening grade associated with 
increased risk for death and particularly for cardiac 
arrest 
Blood pressure monitoring reduced the risk for 
cardiac arrest-related death 
 Time frame of 
postoperative horse 
observation included 
the first 7 days post-
surgery 
(Data collected May 
1997 to Sept 1999) 
Excluding 
emergency 
abdominal 
procedures, 
mortality: 
Unknown numerator 
and denominator 
(0.9%) 
Abdominal, n = 17 
CNS/spinal cord malacia, 
n = 5 
Other, n = 22 
‡Non-fatal PAM was 
more common (n = 57) 
Surgery type: emergency abdominal surgery 
associated with increased risk but fracture fixations 
associated with the highest risk of mortality 
Age: mortality was lowest overall in yearlings 
No overall difference between isoflurane and 
halothane for overall mortality or non-fatal 
perioperative complications, except: isoflurane was 
associated with lower overall mortality and fewer 
non-fatal perioperative complications in horses 
aged 2–5 years, and with fewer cardiac arrest-
related deaths, especially for horses of worse 
physical status. However, isoflurane had an 
apparent association with an increased risk for 
CNS/spinal cord malacia-associated death 
 Regarding PAM: increased duration (> 90 minutes) 
of anaesthesia and lateral recumbency increased 
risk 
Bidwell et al. (2007) 
Single centre, 
included emergency 
and elective cases 
Horses were 
observed throughout 
the immediate 
recovery period and 
also for 7 days 
(Data collected 1997 
to 2001) 
21/17,961 (0.12%) 
Including those 
which died or were 
euthanized within 
7 days of surgery: 
42/17,961 (0.24%) 
Immediate perioperative 
deaths: 
Intraoperative cardiac 
arrests, n = 10 (five sick 
foals, one sick mature 
horse, four athletic mature 
horses originally deemed 
healthy, although two had 
signs of mild infection 
preoperatively: two 
preceded by AV block, 
initially responsive to 
atropine; one preceded by 
Only descriptive statistics 
performed 
Authors warned of horses with preoperative 
evidence of systemic infection (pyrexia; increased 
white blood cell count) 
Majority of recoveries were rope-assisted but this 
did not always prevent problems 
Duration of most anaesthetics was < 60 minutes 
with a limited number of anaesthetic protocols 
No fatalities were reported for cases maintained by 
TIVA techniques 
It was noted that seven of the eight horses to suffer 
fractures were aged 9–18 years; three had presented 
for colic and three for dystocia. Body mass in these 
seven horses was 400–650 kg 
 VPCs and ventricular 
tachycardia which became 
unresponsive to lidocaine; 
one arrested upon tracheal 
intubation) 
Fractures, n = 8 
PAM/N, n = 3 
Deaths within the 7 days 
post-surgery: 
Colon ruptures, n = 11 
Peritonitis, n = 6 
Uterine artery rupture, 
n = 3  
Sepsis, n = 1 
Senior et al. (2007) 2/861 (0.2%) Mortalities:   
 Multicentre (all 
UK), excluded colics 
Horses were 
observed throughout 
the immediate 
recovery period and 
also for 72 hours 
post-surgery 
(Data collected Apr 
2004 to Jun 2005) 
The two fatal 
fractures occurred at 
one of the centres, 
for which the 
mortality rate was 
therefore: 
2/257 (0.8%) 
Fractures, n = 2 (one 
cervical spine, one 
humerus) 
Morbidities: 
PAC, n = 45 
Prolonged recoveries, 
n = 37 
(> 30 minutes hour−1 of 
GA) 
Thrombophlebitis, n = 8 
Pyrexia, n = 6 
Wounds sustained in 
recovery, n = 6 
Lameness/PAM/N, n = 5 
Carpal chip fracture, n = 1 
Colitis/diarrhoea, n = 5 
 PARO, n = 3 
Dugdale et al. 
(2015) 
Single centre, 
included emergency 
and elective cases 
Horses were only 
observed throughout 
the recovery period, 
until they left the 
recovery box 
(Data collected May 
2010 to end Dec 
2013) 
14/1268 (1.1%) 
overall mortality 
7/782 (0.9%) for 
healthy, elective 
cases 
7/450 (1.6%) for 
colic emergencies 
0/36 (0%) for non-
colic emergencies 
Mortality 
In healthy cases: 
Fractures, n = 5 
PAM, n = 1 
Spinal cord malacia, n = 1 
In colics: 
Fractures, n = 4 
Carpal dislocation, n = 1 
PARO, n = 2 
In non-colic emergencies: 
0 
Breed 
Body mass 
Sex 
Note: increasing body 
mass was found to be a 
risk factor for poorer 
recovery quality 
Physical status: increasing ASA grades associated 
with greater risk 
Age: increasing age associated with increasing risk 
Dorsal recumbency associated with increased risk 
compared with either lateral* 
Anaesthetic maintenance with 
isoflurane/sevoflurane increased risk compared 
with halothane, desflurane or TIVA* 
Shorter anaesthetic duration increased risk* 
Colic surgeries without resection were at greater 
risk* 
*Colic was a confounder of dorsal recumbency; 
colics were more likely to have had anaesthesia 
maintained with isoflurane or sevoflurane, and 
colics euthanized early during surgery, therefore 
 without resections, confounded shorter duration 
anaesthetics 
Worse recoveries were noted to occur with: 
Greater ASA physical status* 
Increasing body mass† 
Short duration of anaesthesia* 
Out-of-hours anaesthesia 
*Age was a covariate of ASA physical status and 
colic surgery; cases with poor prognoses tended to 
be euthanized early under anaesthetic 
†Breed type was a covariate of body mass 
ASA, American Society of Anesthesiologists [classification of physical status from 1 (healthy) to 5 (moribund and not expected to survive 867 
> 24 hours)]; AV, atrioventricular CEPEF, Confidential Enquiry into Perioperative Equine Fatalities; CNS, central nervous system; C-section, 868 
Caesarean section; CV, cardiovascular; CVR,  cardiovascular and respiratory ENT, ear, nose, throat; ETT, endotracheal tube; GA, general 869 
anaesthesia; GG, guaiphenesin (pseudonym: glyceryl guaiacolate ether) IH, inhalation IV, intravenous; OOH, out of hours; PAC, post-870 
 anaesthesia colic; PAM/N, post-anaesthesia myopathy/neuropathy; PARO, post-anaesthesia respiratory obstruction; TIVA, total intravenous 871 
anaesthesia; VPC, ventricular premature complex/contraction. *†‡Indicate associated information within the same row (study). 872 
